Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
A Prospective Open-Label Study of Aripiprazole in the Management of Patients With Schizophrenia in General Psychiatric Practices
This study has finished and is no longer accepting participants.
Location not clearly listed
A Study of Strategies to Improve Schizophrenia Treatment
This study has finished and is no longer accepting participants.
Multiple locations, including FayettevilleA Randomized, Single-Dose, Open-Label, Parallel-Group Study to Determine the Relative Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveA Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveThis study has finished and is no longer accepting participants.
In PittsburghCognitive and Negative Symptoms in Schizophrenia Trial (CONSIST)
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesAgomelatine Treatment of Major Depressive Episodes in the Course of Schizophrenic Psychoses (AGOPSYCH)
This study has finished and is no longer accepting participants.
In MannheimAllopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Bat YamResearchers studied Risperidone Long-Acting Injectable (RLAI) to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In Seoul
Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia (REINTEGRA Study)
This study has finished and is no longer accepting participants.
Location not clearly listedThis study ended early.
In TorontoLocus Coeruleus Neuroimaging of Antipsychotic/Modafinil Interactions on Cognition in Schizophrenia
This study ended early.
In San FranciscoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.